Delivery Order SPE2DB22D2206-SPE2DB22FED33
Award Date 8/3/22
Potential Completion Date 8/24/22
Potential Value $131K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 300 mg/10 mL vials of the pharmaceutical product OCREVUS. The $163,964.25 award has a completion date of March 10, 2022 and was made on February 16, 2022. Amerisourcebergen Drug Corp is a prime contractor that has received multiple DLA awards to provide pharmaceuticals, medical supplies, and related distribution services in...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 300 mg/10 mL vials of the pharmaceutical product Ocrevus. The $131,171.40 award has an August 18, 2022 completion date and was made on July 28, 2022. No set-aside designation was used. AmerisourceBergen Drug Corp, through its Corporate Office division, is an experienced government contractor that has received numerous DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide OCREVUS 300 MG/10 ML VIAL 10ML. The $23,118.08 contract has a June 3, 2024 ultimate completion date. This award is made under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product OCREVUS 300 MG/10 ML VIAL 10ML. The order has a potential value of $23,118.08 and a completion date of March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC) the company...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OCREVUS 300 mg/10 mL vials. The delivery order, valued at $23,118.08, has an ultimate completion date of April 22, 2024. This award is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a period of performance through...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 300 mg/10 ml vials of the pharmaceutical product OCREVUS. The $112,653.60 delivery order has a completion date of May 25, 2023 and was awarded on May 4, 2023. No set-aside designation was used. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceuticals, medical supplies, and...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide OCREVUS 300 MG/10 ML vials. The $109,309.50 award has an April 7, 2022 completion date and was issued on March 17, 2022. AmerisourceBergen, a large pharmaceutical distributor, has previously received numerous DLA delivery orders to supply pharmaceuticals, medical supplies, and distribution services in...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 300 mg/10 mL vials of the pharmaceutical product OCREVUS. The contract has a potential value of $34,677.12 and a completion date of March 7, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of OCREVUS 300 MG/10 ML VIAL 10ML, a specialty pharmaceutical product. The award has a ceiling value of $115,590.40 and a period of performance through April 10, 2024. This order is placed against an indefinite delivery contract (IDC) previously awarded to AmerisourceBergen Drug Corp by DLA, with a potential...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OCREVUS 300 mg/10 ml vials. The total potential value of the award is $128,918.52, with a completion date of October 15, 2021. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to provide pharmaceuticals, medical supplies, and...